Over the course of 2007 to 2021, growth stocks dramatically outperformed value stocks. Historically low interest rates, coupled with the emergence of the knowledge economy, sparked one of the longest bull markets in growth stocks in history.

Nonetheless, value stocks took center stage last year in response to rising interest rates and geopolitical turmoil. This pronounced value tilt sent growth-stock valuations tumbling almost across the board. This year, pure-play growth equities have rebounded to a degree, due to the excitement over artificial intelligence (AI), but bargains still abound in the space. 

Two growth stocks that deserve a closer look are Intellia Therapeutics (NASDAQ: NTLA) and Palantir Technologies (NYSE: PLTR). Intellia Therapeutics is one of the early leaders in the emerging field of genomic medicine. Palantir is a software powerhouse that specializes in data analysis and intelligence solutions.

Continue reading

Source Fool.com